What are diagnosis of the urologists for the causes of erectile dysfunction in patients with nonalcoholic fatty liver disease? An observational study.
Recruiting
- Conditions
- onalcoholic fatty liver diseaseErectile dysfunction
- Registration Number
- ACTRN12617000433303
- Lead Sponsor
- Deniz DUMA
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Male
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms link nonalcoholic fatty liver disease to erectile dysfunction in urology practice?
What are the comparative effectiveness of standard-of-care treatments for erectile dysfunction in nonalcoholic fatty liver disease patients?
Which biomarkers are associated with erectile dysfunction severity in nonalcoholic fatty liver disease subtypes?
What adverse events are commonly observed in nonalcoholic fatty liver disease patients with erectile dysfunction and how are they managed?
Are there any combination therapies or related compounds being explored for treating erectile dysfunction in nonalcoholic fatty liver disease patients?